Dr. Amanda B. Reed-maldonado, MD Urology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 |
Dr. Frank A Wojciechowski, D.O. Urology Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-1163 Fax: 210-916-5076 |
Dr. Necia Mcree Pope, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: Brooke Army Medical Center, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234 Phone: 210-916-0716 |
Eric C Umbreit, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 |
Dr. Christopher L Allam, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 |
Dr. David Barham, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-4141 |
Dr. Jessica Brooke Saeger, MD Urology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-0439 |
Dr. Rafael Vidal Mora, M.D. Urology Medicare: Medicare Enrolled Practice Location: 3851 Roger Brooke Dr, Bamc - Mche - Qd ( Creds ), Fort Sam Houston, TX 78234 Phone: 210-916-1163 |
News Archive
Vertex pharmaceuticals jumped 10 percent in value on the Nasdaq after U.S. regulators FDA said the company's experimental hepatitis C drug cures more patients than current therapies.
Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial.
Improving acute pain management after traumatic injury remains a priority for policymakers and clinicians as rates of injury and subsequent pain-related disability rise nationally. Yet, innovations in trauma pain management remain understudied.
Boston Scientific Corporation today announced it has acquired Intelect Medical, Inc., a development-stage company located in Boston. Intelect Medical is developing advanced neuromodulation technologies for deep brain stimulation therapy.
In a recent development, doctors have warned regarding the possibly toxicities of common pain killer Ibuprofen adding that it can lead to a potentially fatal condition which can be triggered, in rare cases, by even a standard dose. The condition in question is called renal tubular acidosis (RTA). The research is published in the Medical Journal of Australia.
› Verified 3 days ago